Evidence map›Paper›PMID 21157972›Full record

ReviewWorld journal of gastroenterology2010

Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.

Matteo Pedrelli, Camilla Pramfalk, Paolo Parini

Open access · greenAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Modulation of Hepatic Functions by Chicory (Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Thyromimetics: What does the future hold?Indian journal of endocrinology and metabolism · 2012
    Article
  13. Article
  14. Article
  15. Reverse cholesterol transport revisited.World journal of gastroenterology · 2010
    Article
  16. Thyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matteo PedrelliDivision of Clinical Chemistry, Department of Laboratory Medicine, Molecular Nutrition Unit, Karolinska Institutet at Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden.
Camilla Pramfalk
Paolo Parini
Karolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reverse cholesterol transport (RCT) is a complex process which transfers cholesterol from peripheral cells to the liver for subsequent elimination from the body via feces. Thyroid hormones (THs) affect growth, development, and metabolism in almost all tissues. THs exert their actions by binding to thyroid hormone receptors (TRs). There are two major subtypes of TRs, TRα and TRβ, and several isoforms (e.g. TRα1, TRα2, TRβ1, and TRβ2). Activation of TRα1 affects heart rate, whereas activation of TRβ1 has positive effects on lipid and lipoprotein metabolism. Consequently, particular interest has been focused on the development of thyromimetic compounds targeting TRβ1, not only because of their ability to lower plasma cholesterol but also due their ability to stimulate RCT, at least in pre-clinical models. In this review we focus on THs, TRs, and on the effects of TRβ1-modulating thyromimetics on RCT in various animal models and in humans.

Indexed as

AnimalsBile Acids and SaltsBiological TransportCholesterolHumansProtein IsoformsReceptors, Thyroid HormoneThyroid HormonesBile Acids and SaltsCholesterolProtein IsoformsReceptors, Thyroid HormoneThyroid Hormones

Identifiers

PMID21157972
PMCPMC3007105
OpenAlexW1498090172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.